These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 12954810)

  • 1. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy.
    Wallace MJ; Blair RE; Falenski KW; Martin BR; DeLorenzo RJ
    J Pharmacol Exp Ther; 2003 Oct; 307(1):129-37. PubMed ID: 12954810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity.
    Wallace MJ; Martin BR; DeLorenzo RJ
    Eur J Pharmacol; 2002 Oct; 452(3):295-301. PubMed ID: 12359270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.
    Wallace MJ; Wiley JL; Martin BR; DeLorenzo RJ
    Eur J Pharmacol; 2001 Sep; 428(1):51-7. PubMed ID: 11779037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus.
    Blair RE; Deshpande LS; Sombati S; Falenski KW; Martin BR; DeLorenzo RJ
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1072-8. PubMed ID: 16469864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy.
    Falenski KW; Blair RE; Sim-Selley LJ; Martin BR; DeLorenzo RJ
    Neuroscience; 2007 May; 146(3):1232-44. PubMed ID: 17433556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid and nitric oxide signaling interplay in the modulation of hippocampal hyperexcitability: Study on electrophysiological and behavioral models of temporal lobe epilepsy in the rat.
    Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
    Neuroscience; 2015 Sep; 303():149-59. PubMed ID: 26135674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats.
    Kozan R; Ayyildiz M; Agar E
    Epilepsia; 2009 Jul; 50(7):1760-7. PubMed ID: 19453709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
    Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
    J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.
    Hill TD; Cascio MG; Romano B; Duncan M; Pertwee RG; Williams CM; Whalley BJ; Hill AJ
    Br J Pharmacol; 2013 Oct; 170(3):679-92. PubMed ID: 23902406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-type calcium channel mediates anticonvulsant effect of cannabinoids in acute and chronic murine models of seizure.
    Naderi N; Ahmad-Molaei L; Mazar-Atabaki A; Ronaghi A; Shirazi-zand Z; Motiei-Langroudi SM; Eslahkar S
    Neurochem Res; 2012 Feb; 37(2):279-87. PubMed ID: 21928146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.
    Deshpande LS; Sombati S; Blair RE; Carter DS; Martin BR; DeLorenzo RJ
    Neurosci Lett; 2007 Jan; 411(1):11-6. PubMed ID: 17110038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy.
    Bhaskaran MD; Smith BN
    Exp Neurol; 2010 Jun; 223(2):529-36. PubMed ID: 20144892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice.
    Naderi N; Aziz Ahari F; Shafaghi B; Najarkolaei AH; Motamedi F
    J Neural Transm (Vienna); 2008 Nov; 115(11):1501-11. PubMed ID: 18575801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration.
    Sim-Selley LJ; Schechter NS; Rorrer WK; Dalton GD; Hernandez J; Martin BR; Selley DE
    Mol Pharmacol; 2006 Sep; 70(3):986-96. PubMed ID: 16760363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of spontaneous seizures in rats correlates with alterations in sensorimotor gating, spatial working memory, and parvalbumin expression throughout limbic regions.
    Wolf DC; Bueno-Júnior LS; Lopes-Aguiar C; Do Val Da Silva RA; Kandratavicius L; Leite JP
    Neuroscience; 2016 Jan; 312():86-98. PubMed ID: 26582750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble epoxide hydrolase activity regulates inflammatory responses and seizure generation in two mouse models of temporal lobe epilepsy.
    Hung YW; Hung SW; Wu YC; Wong LK; Lai MT; Shih YH; Lee TS; Lin YY
    Brain Behav Immun; 2015 Jan; 43():118-29. PubMed ID: 25135858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid.
    Calignano A; La Rana G; Makriyannis A; Lin SY; Beltramo M; Piomelli D
    Eur J Pharmacol; 1997 Dec; 340(2-3):R7-8. PubMed ID: 9537804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin growth factor-1 (IGF-1) enhances hippocampal excitatory and seizure activity through IGF-1 receptor-mediated mechanisms in the epileptic brain.
    Jiang G; Wang W; Cao Q; Gu J; Mi X; Wang K; Chen G; Wang X
    Clin Sci (Lond); 2015 Dec; 129(12):1047-60. PubMed ID: 26286172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats.
    Huizenga MN; Wicker E; Beck VC; Forcelli PA
    Epilepsia; 2017 Sep; 58(9):1593-1602. PubMed ID: 28691158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures.
    Bojnik E; Turunç E; Armağan G; Kanıt L; Benyhe S; Yalçın A; Borsodi A
    Epilepsy Res; 2012 Mar; 99(1-2):64-8. PubMed ID: 22079489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.